Search filters

List of works by Mirko Marabese

Across the universe of K-RAS mutations in non-small-cell-lung cancer.

scientific article published on January 2014

Activity of Birinapant, a SMAC Mimetic Compound, Alone or in Combination in NSCLCs With Different Mutations

scientific article published on 22 October 2020

Assessment of proportional hazard assumption in aggregate data: a systematic review on statistical methodology in clinical trials using time-to-event endpoint

scientific article published on 13 November 2018

Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells.

scientific article published on 2 September 2015

Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells.

scientific article

Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach

scientific article published on 04 December 2018

Combination of trabectedin and irinotecan is highly effective in a human rhabdomyosarcoma xenograft

scientific article published on September 2005

Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo.

scientific article published on 22 June 2016

DNA damage induces transcriptional activation of p73 by removing C-EBP repression on E2F1 ⬇️

scientific article published on November 15, 2003

DNA repair gene polymorphisms in non-small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.

scientific article published on 7 July 2016

DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer

scientific article published on 13 December 2011

Different metabolic responses to PI3K inhibition in NSCLC cells harboring wild-type and G12C mutant KRAS.

scientific article published on 6 June 2016

Down-regulation of the nucleotide excision repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells

scientific article

Effects of inducible overexpression of DNp73alpha on cancer cell growth and response to treatment in vitro and in vivo.

scientific article

Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial

scientific article published on 19 December 2018

G48A, a New KRAS Mutation Found in Lung Adenocarcinoma.

scientific article published on 4 April 2016

Genetic markers for prediction of treatment outcomes in ovarian cancer.

scientific article published on 08 July 2014

Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation

scientific article published on 23 July 2020

KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy

scientific article published on 15 September 2015

KRas-LCS6 polymorphism does not impact on outcomes in ovarian cancer.

scientific article published on 21 April 2012

LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors

scientific article published on 18 October 2019

Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC

scientific article published on 24 August 2018

Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker.

scientific article

Oral prolonged-release Oxycodone-Naloxone: analgesic response, safety profile, and factors influencing the response in advanced cancer patients

scientific article published on 27 March 2019

P73a overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line.

scientific article

Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy

scientific article published on 30 July 2020

RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patients

scientific article published on 3 August 2018

RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma

scientific article published on 03 July 2018

Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients.

scientific article

Role of Cetuximab in the Treatment of Patients With NSCLC: Are We Throwing Out the Baby With the Bath Water?

scientific article published on 28 June 2010

Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)

scientific article

The 5'UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs

scientific article published on 14 December 2016

Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models

scientific article published on 09 July 2018

Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial.

scientific article

Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.

scientific article published on 17 January 2018

p73 overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis

scientific article published on 01 November 2001

p73: a chiaroscuro gene in cancer.

scientific article

ΔNp63 expression is associated with poor survival in ovarian cancer

scientific article published on 12 November 2007

∆Np73beta induces caveolin-1 in human non-small cell lung cancer cell line H1299.

scientific article published on 4 September 2015

Paulina is supported by:

About Paulina

Help